In line with this, the immunofluorescence analysis and reanalysis of scRNAseq datasets provided further evidence supporting the predominant expression of MRGPRX2 on MCs in both healthy donor skin and MF patients’ skin (13, 14). The gene discussed is MRGPRX2; the disease is mycosis fungoides.